A Phase I Study of GT300 in Healthy Subjects

NCT04963855 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Lewy Body Disease

Interventions

DRUG: GT300
DRUG: Microcrystalline cellulose

Sponsor

Generian Pharmaceuticals, Inc.